We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr And Eli Lilly Head Back To Court Over Prozac

Law360 (May 11, 2006, 12:00 AM EDT) -- Five years after successfully challenging a patent for Eli Lilly’s blockbuster antidepressant Prozac, Barr Laboratories and Eli Lilly will meet again in court, this time over a reissue patent for the drug.

The suit, filed by Lilly in the U.S. District Court for the Southern District of Indiana, seeks a patent infringement ruling for the patents challenged by Barr, and a declaratory judgment ruling upholding the validity of the patent.

The suit is the result of a reissue patent covering a 90 mg capsule of Prozac...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.